---
url: "https://www.lek.com/leadership/sue-st-sure"
title: "Sue St. Sure | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/sue-st-sure#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Sue St. Sure

Sue St. Sure is a Managing Director and Partner, in L.E.K. Consulting's Los Angeles office. She most recently served as the West Coast Biopharmaceuticals & Life Sciences practice leader. Sue has more than 24 years experience assisting companies globally in corporate and business unit strategy consulting and merger and acquisition advisory support. She has worked across many biopharmaceutical, therapeutic, and technology segments and has assisted clients with issues such as strategic opportunity evaluations, product prioritization, product planning and commercialization, strategic partnering, and mergers and acquisitions. Sue has also worked across a wide range of therapeutic and technology areas.

Sue earned a Master of Business Administration from the Anderson School at the University of California, Los Angeles (UCLA) and completed graduate work in Neuroscience at the University of California, San Diego. She also received her Bachelor of Arts degree from UCLA, where she graduated Phi Beta Kappa and summa cum laude.

### Education

**Undergraduate:** Bachelor of Arts, University of California, Los Angeles

**Graduate:** Master of Business Administration, Anderson School at the University of California

![Sue St. Sure, L.E.K. Consulting](https://www.lek.com/sites/default/files/profile-images/sue-stsure_web-gmc.jpg)

### Sue's Expertise

#### Capabilities

[Marketing & Sales](https://www.lek.com/capabilities/marketing-and-sales)

[Strategy](https://www.lek.com/capabilities/strategy)

[Mergers & Acquisitions](https://www.lek.com/capabilities/mergers-acquisitions)

[Value Activation](https://www.lek.com/capabilities/organizational-strategy/value-activation)

[Transformation](https://www.lek.com/capabilities/organizational-strategy/transformation)

Read more

### Related Insights

[Case Study\\
\\
\\
**Life Sciences & Pharma****Building Resilience in a Commercial-Stage Pharma Company’s Supply Chain**\\
\\
April 16, 2025](https://www.lek.com/insights/hea/us/cs/building-resilience-commercial-stage-pharma-companys-supply-chain)

[Case Study\\
\\
\\
**Life Sciences & Pharma****Unlocking the Potential of Next-Generation PROTACs: A Strategic Roadmap for R&D Investment**\\
\\
March 7, 2025\\
\\
Our client engaged L.E.K. Consulting to develop a market overview across multiple key therapeutic areas (e.g., oncology, immunology, neuroscience) and…](https://www.lek.com/insights/hea/us/cs/unlocking-potential-next-generation-protacs-strategic-roadmap-rd-investment)

[Case Study\\
\\
\\
**Data & Analytics****Predicting Pandemics: Models Deliver 90% Forecast Accuracy for Biopharma Giant**\\
\\
June 17, 2024](https://www.lek.com/insights/all/us/cs/predicting-pandemics-models-deliver-90-forecast-accuracy-biopharma-giant)

[Case Study\\
\\
\\
**Life Sciences & Pharma****Cost and Reimbursement Assessment for a Biopharmaceutical Company**\\
\\
May 7, 2024\\
\\
A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies](https://www.lek.com/insights/hea/global/cs/cost-and-reimbursement-assessment-biopharmaceutical-company)

[Special Report\\
\\
\\
**Healthcare Services****Changing the Future of Chilean Women**\\
\\
October 26, 2020\\
\\
In 2018, almost 2.1 million women were diagnosed with breast cancer, and more than 630,000 female patients died from it.](https://www.lek.com/insights/sr/changing-future-chilean-women)

[Published Articles\\
\\
\\
**Life Sciences & Pharma****Beyond Pills: Designing a Winning Delivery Strategy for the New Era of Biologics**\\
\\
July 31, 2015\\
\\
With the rise of biologics, drug delivery presents new challenges as many companies are still taking a fragmented approach, resulting in delayed (or…](https://www.rdmag.com/article/2015/07/beyond-pills-designing-winning-delivery-strategy-new-era-biologics)

- [Load more](https://www.lek.com/leadership/sue-st-sure?page=1 "Load more items")

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×